Skip to main content
Premium Trial:

Request an Annual Quote

Wiratech to Distribute iRepertoire Reagent Kits in Parts of Europe

NEW YORK (GenomeWeb) – iRepertoire today announced a deal with Wiratech to distribute iRepertoire's reagent kits in parts of Europe.

The deal covers France, Spain, Portugal, the Benelux region, and Switzerland. Based in Paris, Wiratech has expertise in HLA typing that complements iRepertoire's immune system profiling products and services, the Huntsville, Ala., firm said.

iRepertoire uses immune repertoire sequencing to gain insight into the body's immunological memory of past infection and disease, which can provide information about how the body has responded to such events. The firm said that its market will be in clinical and research applications that require immune evaluation, such as drug treatment monitoring, identification of minimal residual disease, immune monitoring following stem cell transplantation, vaccine studies, and biomarker development.

Financial and other terms of the agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.